Table 5

Clinical Outcomes

IFC (n = 32)RFC (n = 63)p Value
30 days
 MACCE2 (6.2)1 (1.6)0.26
  Death1 (3.1)0 (0.0)0.34
   Cardiac1 (3.1)0 (0.0)0.34
   Noncardiac0 (0.0)0 (0.0)1.00
  Reinfarction0 (0.0)1 (1.6)1.00
  Stroke1 (3.1)0 (0.0)0.34
  Stent thrombosis0 (0.0)1 (1.6)1.00
   Definite0 (0.0)1 (1.6)1.00
   Probable0 (0.0)0 (0.0)1.00
  Ischemia-driven TLR0 (0.0)1 (1.6)1.00
 Target vessel revascularization0 (0.0)1 (1.6)1.00
1 Year
 MACCE3 (9.4)4 (6.3)0.68
  Death3 (9.4)2 (3.2)0.33
   Cardiac2 (6.4)0 (0.0)0.11
   Noncardiac1 (3.1)2 (3.2)1.00
  Reinfarction0 (0.0)1 (1.6)1.00
  Stroke1 (3.1)0 (0.0)0.34
  Stent thrombosis0 (0.0)1 (1.6)1.00
   Definite0 (0.0)1 (1.6)1.00
   Probable0 (0.0)0 (0.0)1.00
  Ischemia-driven TLR0 (0.0)4 (6.3)0.30
 Target vessel revascularization1 (3.1)7 (11.1)0.26

Values are n (%).

MACCE = major adverse cardiac or cerebrovascular events; TLR = target lesion revascularization; other abbreviations as in Table 1.